Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

People who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated.Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incid...

Full description

Bibliographic Details
Main Authors: Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, M-J Milloy, Kora DeBeck, Julio Montaner, Annick Simo, Mel Krajden, Gregory J Dore, Thomas Kerr, Evan Wood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4045728?pdf=render
_version_ 1811197705305718784
author Jason Grebely
Viviane Dias Lima
Brandon D L Marshall
M-J Milloy
Kora DeBeck
Julio Montaner
Annick Simo
Mel Krajden
Gregory J Dore
Thomas Kerr
Evan Wood
author_facet Jason Grebely
Viviane Dias Lima
Brandon D L Marshall
M-J Milloy
Kora DeBeck
Julio Montaner
Annick Simo
Mel Krajden
Gregory J Dore
Thomas Kerr
Evan Wood
author_sort Jason Grebely
collection DOAJ
description People who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated.Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incidence were evaluated. Factors associated with time to HCV infection were assessed using Cox proportional hazards regression.Among 2,589, 82% (n = 2,121) were HCV antibody-positive at enrollment. Among 364 HCV antibody-negative participants with recent (last 30 days) injecting at enrollment, 126 HCV seroconversions were observed [Overall HCV incidence density: 8.6 cases/100 person-years (py); 95% confidence interval (95% CI): 7.2, 10.1; HCV incidence density among those with injecting during follow-up: 11.5 cases/100 py; 95% CI 9.7, 13.6]. The overall HCV incidence density declined significantly from 25.0/100 py (95% CI: 20.2, 30.3) in 1996-99, as compared to 6.0/100 py (95% CI: 4.1, 8.5) in 2000-2005, and 3.1/100 py (95% CI: 2.0, 4.8) in 2006-2012. Among those with injecting during follow-up, the overall HCV incidence density declined significantly from 27.9/100 py (95% CI: 22.6, 33.6) in 1996-99, as compared to 7.5/100 py (95% CI: 5.1, 10.6) in 2000-2005, and 4.9/100 py (95% CI: 3.1, 7.4) in 2006-2012. Unstable housing, HIV infection, and injecting of cocaine, heroin and methamphetamine were independently associated with HCV seroconversion.HCV incidence has dramatically declined among PWID in this setting. However, improved public health strategies to prevent and treat HCV are urgently required to reduce HCV-associated morbidity and mortality.
first_indexed 2024-04-12T01:18:50Z
format Article
id doaj.art-899921bef3c645e586274877f3235257
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T01:18:50Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-899921bef3c645e586274877f32352572022-12-22T03:53:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9772610.1371/journal.pone.0097726Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.Jason GrebelyViviane Dias LimaBrandon D L MarshallM-J MilloyKora DeBeckJulio MontanerAnnick SimoMel KrajdenGregory J DoreThomas KerrEvan WoodPeople who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated.Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incidence were evaluated. Factors associated with time to HCV infection were assessed using Cox proportional hazards regression.Among 2,589, 82% (n = 2,121) were HCV antibody-positive at enrollment. Among 364 HCV antibody-negative participants with recent (last 30 days) injecting at enrollment, 126 HCV seroconversions were observed [Overall HCV incidence density: 8.6 cases/100 person-years (py); 95% confidence interval (95% CI): 7.2, 10.1; HCV incidence density among those with injecting during follow-up: 11.5 cases/100 py; 95% CI 9.7, 13.6]. The overall HCV incidence density declined significantly from 25.0/100 py (95% CI: 20.2, 30.3) in 1996-99, as compared to 6.0/100 py (95% CI: 4.1, 8.5) in 2000-2005, and 3.1/100 py (95% CI: 2.0, 4.8) in 2006-2012. Among those with injecting during follow-up, the overall HCV incidence density declined significantly from 27.9/100 py (95% CI: 22.6, 33.6) in 1996-99, as compared to 7.5/100 py (95% CI: 5.1, 10.6) in 2000-2005, and 4.9/100 py (95% CI: 3.1, 7.4) in 2006-2012. Unstable housing, HIV infection, and injecting of cocaine, heroin and methamphetamine were independently associated with HCV seroconversion.HCV incidence has dramatically declined among PWID in this setting. However, improved public health strategies to prevent and treat HCV are urgently required to reduce HCV-associated morbidity and mortality.http://europepmc.org/articles/PMC4045728?pdf=render
spellingShingle Jason Grebely
Viviane Dias Lima
Brandon D L Marshall
M-J Milloy
Kora DeBeck
Julio Montaner
Annick Simo
Mel Krajden
Gregory J Dore
Thomas Kerr
Evan Wood
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
PLoS ONE
title Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
title_full Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
title_fullStr Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
title_full_unstemmed Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
title_short Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.
title_sort declining incidence of hepatitis c virus infection among people who inject drugs in a canadian setting 1996 2012
url http://europepmc.org/articles/PMC4045728?pdf=render
work_keys_str_mv AT jasongrebely decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT vivianediaslima decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT brandondlmarshall decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT mjmilloy decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT koradebeck decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT juliomontaner decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT annicksimo decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT melkrajden decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT gregoryjdore decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT thomaskerr decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012
AT evanwood decliningincidenceofhepatitiscvirusinfectionamongpeoplewhoinjectdrugsinacanadiansetting19962012